The study was the first randomised trial to test the abdominal stitch in this group of women. More: New treatment could reduce preterm birth and “save lives” Source: News
read more42.2% of non-radiographic axial spondyloarthritis patients showed a significant and clinically meaningful reduction in disease activity. More: Cosentyx hits endpoints in axSpA trial Source: News
read moreGilead will now initiate two new clinical trials, for both treatment-naïve and multidrug resistant HIV-1. More: Investigational HIV therapy shows early-stage promise Source: News
read moreThe committee initially published a draft final appraisal for the drug in October, and just last week the SMC approved the treatment for use on NHS Scotland. More: NICE recommends Elmiron for bladder pain syndrome Source: News
read morePatients had 50% fewer flares on the drug compared to placebo. More: Nucala becomes first med to significantly reduce HES flares Source: News
read moreFinding the perfect name is no easy task for a new company, particularly in the exotic world of biopharma monikers. Mylan and Pfizer’s Upjohn business, working to close their generics megamerger, believe they have one that strikes the right tone—even
read more© 1994 - 2026 B.M. Pharmaceuticals